Investments

profilebarbara1975
RichardsonInvestmentnotebook20180428.xlsx

style scan


Ryan Singh: I have choosen large cap vs small cap as I like companies that are seasoned in the industry. Most of the companies I have selected have multiple segments which are well diversified in my eyes as they can have multiple positive cash flows coming in when one segment may be negative. To me this is a hedge in which I can have a lot of confidence that my returns will stay mainly positive and not lose a great deal of money on investing in them. Small Caps may turn out to be diamonds in the ruff and can yield high returns but this is mainly a bet I would stay away from as it has a lot of risk involved and may be bought over from a large cap company when trouble arises. I have choosen growth vs value for mainly the same reasons above as I think growth has a lot of cash on hand that can invest in R&D and develope cutting edge technological products that appeal to consumers. Growth stocks may not have high returns as quickly as value stocks but growth stocks do pay dividends which is another bonus of ownership in the stock. Growth stocks mainly rise overtime and if held long will mainly outperform value stocks in my opinion.

purchase notes

Long Pfizer Inc: I invested in PFE since the company’s price is low and they have recently been approved by the FDA for treating patients with transthyretin cardiomyopathy (TTR-CM). This rare disease is associated with progressive heart failure and is universally fatal according to Zacks. I elected to invest long considering the stock also has attractive financial metrics.
Long Unitedhealth Group Inc: I invested in UNH due to Optum’s first quarter earnings increased from operations by a 16 percent earnings growth rate, saw a revenue growth of $1.6 billion, and OptumInsight’s revenue backlog grew 19 percent or $2.1 billion in the past 12 months, with more than one-half billion dollars added in the first quarter (UnitedHealth Group, 2017). This shows growth potential and increases the company’s value.
Long Medtronic plc: I selected to invest in MDT since they are a medical technology company and recently developed a product that could be advantageous for people diagnosed with diabetes. The company’s annual total revenue is 29.7 billion and their ROE is 12.72 in June 2017. In addition, their financial history indicates an increase in dividends over the past 20 years which is very attractive to shareholders and also indicates sustainability due to very strong earnings performance and strong price/volume activity.
Long Amgen Inc: I selected to invest in AMGN since their earnings per share have increased at an annualized rate of 19.56% in the last five years which could result in an increase in stock prices. The company’s ROE has increased from the previous year at 25.16% which indicates growth. I elected to buy/limit since the company is very attractive financial metrics, very strong earnings performance, neutral price/volume activity and neutral expert activity.
Long AbbVie Inc: I decided to invest long in ABBV because in March 2017, the stock hit a seven-month high which estimated growth assets could bring in up to $20.5 billion in sales over the next five years. In addition, ABBV shares rose 2.1% to 65.88, after earlier rising as much as 3% to touch a high at 66.45 (Gaitlin, 2017).
Long Celgene Corp: I decided to buy/stop CELG due to their average financial metrics, very strong earnings performance, weak price/volume activity and positive expert activity. The company has great growth potential considering their year-on-year change in revenues and earnings are better than the median among its peer group. Also, CELG has the financial and operating capacity to borrow quickly (CapitalCube, 2017). .
Long Bristol-Myers Squibb: I decided to buy/limit BMY due to their poor performance as well as a possible buyout concerns which could be lucrative. The company still has value in product Opdivo since it was beneficial to certain cancer patients despite the poor financial metrics, very strong earnings performance,very weak price/volume activity and very positive expert activity.
Long Gilead Sciences Inc: I selected to invest long in GILD since their stock is priced inexpensively relative to its EPS growth rate in the last five years and earnings per share have grown strongly at an annualized rate of 41.63% which translates into a P/E ratio of 31.71, 74.06% higher than where the stock trades now (MarketGrader, 2017).
Long Allergan plc: I selected to invest long in AGN, but meant to invest short due to its poor financial metrics. The company is considered undervalued due to trading at a lower Price/Book multiple (1.07) than its peer median (3.64). AGN also has low net margins, poor asset turnover, and return on assets over the past five years has remained stagnant compared to competitors. This presents the company as lacking value as well as growth (CapitalCube, 2017).
Long Lilly Eli & Co: I decided to buy/limit LLY because their net income and revenue has fluctuated over the last five years resulting in a decrease in EPS. In addition, their quick ratio of 0.78 is relatively low could cease growth potential. The company reflects average financial metrics, very weak earnings performance, strong price/volume activity and neutral expert activity.
Long Thermo Fisher Scientific: TMO is another long position that was enticing considering on Apr 26, 2017, TMO Inc. reported 1st quarter 2017 earnings of 2.08 per share and exceeded last year's 1st quarter results by 15.56%. Also, the company had 1st quarter 2017 revenues of 4.77 billion which was 10.95% above the prior year's 1st quarter results. This is due to very strong earnings performance, very positive expert activity and strong price/volume activity.
Long Anthem Inc: I selected to invest long in ANTM because of their PE ratio of 15.33%, P/S ratio of 0.55, and its dividend yield of 1.4%. These factors suggest that Anthem is a pretty good value pick, as investors have to pay a relatively low level for each dollar of earnings, and that ANTM has decent revenue metrics to back up its earnings (Zacks, 2017).
Long Aetna Inc: I selected to invest long in AET since their revenue has increased over the past five years. The company’s P/E ratio is 46.4, P/S ratio of 0.70, and its dividend yield of 1.34%. AET first-quarter 2017 earnings were $2.71 per share sand also grew 17% year over year. The company has strong earnings performance and positive expert activity. The stock also has weak price/volume activity (Zacks, 2017).
Long Stryker Corp: I decided to buy/limit SYK since their total revenue was $11.3 billion, and total assets of $20.4 billion, with net profit of 14.5% of sales (8.1% of assets) in 2016. However, I put a limit on the company because of very poor financial metrics, very strong earnings performance, very strong price/volume activity and negative expert activity.
Long Cigna Corporation: CI is another company in the healthcare industry that has maintained leverage because of their significant rise in share price of 12% in March 2017. According to Nasdaq, the company expects adjusted income from operations in the range of $295-$315 million, which translates into year-over-year growth rate of nearly 4%. This is due to very attractive financial metrics, very positive expert activity, strong earnings performance and strong price/volume activity.
Long Boston Scientific Corp: BSX is another buy/limit due to a quick ratio of 0.64, P/S ratio of 3.55, and P/E ratio of 111.36. The company’s revenue has increased over the past five years and shares gained 9.46% from February 2017 despite issues that initially decreased shares. BSX reflects very poor financial metrics, strong earnings performance, strong price/volume activity and neutral expert activity.
Long Regeneron Pharmaceuticals Inc: I decided to buy/limit REGN since 32 billion in revenue was reported by the company last quarter represents just 9.84% growth from the $1.20 billion it sold during the same quarter a year earlier. According to MarketGrader, REGN has shares trade currently at 58.00 times the company's 12-months' earnings per share, more than two times our "optimum" P/E of 13.68.
Long Intuitive Surgical Inc: I selected to invest buy/limit with ISRG because the company is expecting to increase earnings at an average annual rate of 9.44%. This year, analysts are forecasting earnings increase of 5.06% over last year. Analysts expect earnings growth next year of 10.31% over this year's forecasted earnings (Zacks, 2017).
Long Vertex Pharmaceuticals Inc: I decided to buy/limit VRTX considering operations income in 2016 were $39.6 million and revenue from cystic fibrosis drug sales were $454 million. The company closed the year with $1.43 billion in cash, but sales of Kalydeco decreased slightly from $181 million in the year-ago quarter to $177 million in the fourth quarter of 2016.
Long Abbott Laboratories: I decided to buy/stop ABT since revenue, free cash flow, as well as operating income has mainly decreased over the last five years. In addition, ABT’s dividend yield is 2.3% compared to the industry’s average of 1.1%. The company’s Price/Cash Flow is 18.6% compared to the industry’s average of 18.6. ABT reflects poor financial metrics, average earnings performance, strong price/volume activity and positive expert activity.
Long Bristol-Myers Squibb: I decided to buy/limit BMY due to their poor performance as well as a possible buyout concerns which could be lucrative. The company still has value in product Opdivo since it was beneficial to certain cancer patients despite the poor financial metrics, very strong earnings performance,very weak price/volume activity and very positive expert activity.
Long Gilead Sciences Inc: I selected to invest long in GILD since their stock is priced inexpensively relative to its EPS growth rate in the last five years and earnings per share have grown strongly at an annualized rate of 41.63% which translates into a P/E ratio of 31.71, 74.06% higher than where the stock trades now (MarketGrader, 2017).
Long Allergan plc: I selected to invest long in AGN, but meant to invest short due to its poor financial metrics. The company is considered undervalued due to trading at a lower Price/Book multiple (1.07) than its peer median (3.64). AGN also has low net margins, poor asset turnover, and return on assets over the past five years has remained stagnant compared to competitors. This presents the company as lacking value as well as growth (CapitalCube, 2017).
Long Lilly Eli & Co: I decided to buy/limit LLY because their net income and revenue has fluctuated over the last five years resulting in a decrease in EPS. In addition, their quick ratio of 0.78 is relatively low could cease growth potential. The company reflects average financial metrics, very weak earnings performance, strong price/volume activity and neutral expert activity.
Long Thermo Fisher Scientific: TMO is another long position that was enticing considering on Apr 26, 2017, TMO Inc. reported 1st quarter 2017 earnings of 2.08 per share and exceeded last year's 1st quarter results by 15.56%. Also, the company had 1st quarter 2017 revenues of 4.77 billion which was 10.95% above the prior year's 1st quarter results. This is due to very strong earnings performance, very positive expert activity and strong price/volume activity.
Short Biogen Inc: I selected to invest buy/stop in BIIB because their book value per share for the quarter in Mar. 2017 was USD 53.64. Sales increased 21% annually and earnings increased to 35% each year over that period. Yet, BIIB stock traded as high as $334 within the last year. As you might expect, expected growth has slowed considerably. For the year, analysts project flat sales this year (2017) of about $11.3 billion, and modest 7% growth for 2018. Earnings are expected to hover between $21 and $22 per share over the next couple of years according to Fuhrman.
Short Danaher Corp: I selected to invest buy/stop in DHR due to their book value per share growth rate was -3.80% per year as of March 2017. For the quarter ended December 31, 2016, net earnings were $747.0 million, or $1.07 per diluted share which represents a 42.5% year-over-year increase. The company’s future appears positive due to attractive financial metrics, strong earnings performance, very strong price/volume activity and positive expert activity.
Short Humana Inc: I decided to buy/stop HUM since their P/B Ratio is 3.25 and cash flows from operations totaled $1.1 billion in first-quarter 2017. The company has maintained sustainability considering their growth in revenues has increased since 2002. For 2017, the company expects total revenue in the range of $53.5 billion to $54.5 billion. HUM has maintained a competitive advantage due to their attractive financial metrics, strong earnings performance, strong price/volume activity and positive expert activity.
Short McKesson Corp: MCK has a trailing twelve months PE ratio of 12.29 compared to the PE for the S&P 500 stands at about 20.18 in March 2017. This would be considered as undervalued since the stock’s PE compares favorably with the Zacks classified Medical/Dental Supplies industry’s trailing twelve months PE ratio, which stands at 17.37. However, I selected to invest buy/stop because the current quarter consensus estimate has decreased by 2.5% in the past one month, while the full year estimate has decreased by 0.6%.
Short Zoetis Inc: ZTS is considered as overvalued due to the market currently does not expect high earnings growth relative to its peers but seems to expect the company to maintain its relatively high rates of return. While ZTS revenues growth has been below the peer median in the last few years, the market still gives the stock a P/E ratio that is around peer median and seems to see the company as a long-term strategic bet. I selected buy/stop since the company reflects very poor financial metrics, very strong earnings performance, very strong price/volume activity and negative expert activity.

investment log

Purchase info Current info Results
Name Symbol Type Date Price QTY long / short Market Amount (Est) Date Price QTY Market Profit Return 5.1%. Week 4 Assessment Week 6 Assessment Final Assessment
Alaphabet Inc GOOG Equity 3/29/218 $ 1,004.00 20 Long Limit $19,604.01 4/13/218 $ 1,030.05 20 $20,601.00 521.00 2.7% Alphabet current price is $1037.14 it is projected to be at $1269.55 in a year. When Trump signed in the new tax bill for businesses this will add more revenues for Alphabet in the future because less taxes for them to pay. The forward P/E for Alphabet is 25.19 and current P/E is 57.47. If the forward P/E is less than the current P/E the company will expect earnings to grow. Revenue continues to grow each year at about 20% rate for the last 5 years. Has a loss of -0.3%. Tech stock falls because of security infacture. Has a gain of 2.7%. Surging profits as advertisers kept global debate about internet privacy that threatens to affect its main revenue generator. Growth continues as advertising keeps shifting to smartphones. Online tracking and targeting are evolving quickly. Alaphabet has businesses that are not yet contributing significantly to revenue and aoperating cash flow. Alaphabet's earnings also got a multibillion-dollar boost from the company's stakes in startups including Uber Technologies Inc. Alphabet trades at a valuation that justifies a long-term position.
Visa V Equity 3/29/218 $ 119.62 167 Long Market $19,976.54 4/13/218 $ 126.01 167 $21,043.67 1,067.13 5.3% Their stocks cost $119.62 right now and are projected to be at $146.00 in a year. The forward P/E for this stock is 27.17 and current P/E is 39.68. Last year Visa had revenue growth of 21.72% and net income growth of 11.82%. Has a gain of 0.9%. Steady sales growth. Has a gain of 5.39%. Visa reported second-quarter earnings that beat analysts' expectations on Wednesday. Earnings of $1.11 per share were reported and $5.07 billion revenue. Visa CEO said growth in both cross-border and payments volume helped drive the better-than-expected results. Visa said it is raising its forecast for the year. The company now expects adjusted full-year earnings growth in the high 20 percent point range. Visa shares have gained 5 percent so far this year, outperforming the Dow Jones industrial average which has fallen 3 percent in the same period. In February, Visa said it plans to acquire longtime partner Fraedom as the compnay seeks to expand its footprint in the business-to business digital payment industry.
Dollar General DG Equity 3/29/218 $ 93.41 214 Long Limit $19,989.74 4/13/218 $ 98.36 214 $21,049.04 1,059.30 5.3% Dollar General stock cost $93.55 right now analysts predict it to be at $114.00 in a year. The forward P/E for this stock is 15.48 and current P/E is 16.61. In just a couple of months in 2018 Dollar General revenues has grown 6.75% from last year’s revenue and net income grown 23.01%. Has a gain of 3.0%. Sales were up. Has a gain of 5.3%. Dollar General is in the position to meet or exceed 2% sames store sales growth over the next few years. Dollar Tree is down 9.1% for2018. DG now faces more low-end comps tailwinds than headwinds. New tax reforms and modest wage increases will likely drive customers to DG's stores. Its expanding perishable line should also attract higher-income customers.
Skyworks Solutions Inc SWKS Equity 3/29/218 $ 100.00 200 Long Limit $20,000.00 4/13/218 $ 87.08 200 $17,416.00 (2,584.00) -12.9% With technology experts predicting there will be 75 billion connected devices operating worldwide by 2025, Skyworks is uniquely positioned to capitalize on emerging opportunities with the Internet of Things. In every way the world is connected, Skyworks is there. Whether reaching for a smartphone or tablet, setting a smart thermostat, or communicating wirelessly with your medical provider Has a loss of -1.2%. Lower sales than experted. Has a loss of -12.9%. Skyworks will be facing pricing pressure in 2H as Apple moves toward lower-end LCD phones with a higher build of materials than RF supplies. Apple represents 35% to 40% of Skyworks' sales. Although Iphone production to fall 2% year to year in 2H with new models like the Iphone 9 and the Iphone X update down 15% on the year. Apple's Q1 Iphone sales show X weakness.
McDonald's Corp MCD Equity 3/29/218 $ 156.38 127 Long Market $19,860.26 4/13/18 $ 158.30 127 $20,104.10 243.84 1.2% McDonald's had a little pull back and it is an established company. Last year McDonald's had revenue growth of 7.32% and net income growth of 10.79%. The forward P/E for this stock is 20.70 and current P/E is 24.57. Has a loss of -3.4%. McDonalds has been refranchising over the past two years, to lower the proportion of company-owned locations down to 5% from 15%. Has a gain of 1.2%. MCD has declined slightly due to refranchising costs. However, this is temporary and a good potential to buy this stock. The company's refranchising strategy has yielded significant cost savings so far. On the plus side calculating income company-owned stores contribute all of their expenses to the companies expenses, while franchised stores only contribute the expenses needed by MCD to handle the franchise. Due to strong same store sales, Mcdonald has been able to drive higher royalty payments and earnings per share.
Amazon AMZN Equity 3/29/218 $ 1,393.00 14 Long limit $19,502.00 4/13/18 $ 1,572.62 14 $22,016.68 2,514.68 12.9% Jeff Bezos is a excellent CEO, he has created mega company. This company is constantly going into new terrorities, from buying Whole Foods to going into the Health Care territory also. Last year Amazon had revenue growth of 30.80% and net income growth of 27.92%. Has a loss of -1.2%. Tech stock falls because of security infacture. Has a gain of 12.9%. Amazon to increase U.S. Prime membership fee 20%. Amazon shares pop to 6.4% aftermarket on Q1 results that beat revenue estimates with a 43% revenue growth Y/Y. Q2 guidance has in-line revenue from $51B to $54B and operating income from $1.1B to $1.9B. The quarter marks the fifth consecutive quarter that Amazon has beaten on the top-line and guided in-line on revenue. Amazon Web Services revenue rose 49% to $5.44B. Amazon.com has paid about $65M per year to renew its streaming partnership with the NFL to show Thursday Night Football. The company's health care partnership with Berkshire Hathaway and JPMorgan Chase should select its CEO within the next two months. Amazon coming out with the new "Fire TV Cube" also putting out a tease to get customer interest.
Home Depot HD Equity 3/29/218 $ 178.24 112 Long Market $19,962.88 4/13/18 $ 186.46 112 $20,883.52 920.64 1.2% Home Depot is the best stock in their industry, home building material. Last year HD had revenue growth of 6.67% and net income growth of 8.46%. The forward P/E for this stock is 19.05 and current P/E is 24.45. Has a gain of 3.4%. Tax reform is help out Home Depot. Has a gain of 1.2%. Home Depot is setting off on a technology hiring spree. They plan on hiring 1000 new people for its technology team to support an aggressive $11B investment plan into the e-commerce and IT sides of the business. A decline in housing affordability is considered a leading indicator of potential stress in the market for Home Depot. Home Depot trades at a premium to Lowe's which includes a Forward P/E that's 23% more expensive.
MGM Resorts International MGM Equity 3/29/218 $ 35.02 571 Long Market $19,996.42 4/13/18 $ 31.28 571 $17,860.88 (2,135.54) -10.7% I bought this stock when it came out and since I have sold it and I regret I did this. I can this company blowing their competition out of the water. Last year MGM had revenue growth of 13.95% and net income growth of 77.97%. Has a loss of -1.8%. Slow sales reported. Has a loss -10.7%. MGM reports a 1% drop in revenue at U.S. resorts in Q1. Operating income at U.S. resorts fell on lower traffic and fewer conventions during the period. MGM China kicked in with a 25% jump in revenue to $595M as the MGM Cotai contributed. Adjusted property EBITDA was $152M VS $145M a year ago. The company ended the quarter with a cash balance of $1.5B and $13.4B in principal indebtness outstanding. Looking ahead to the second half of the year, MGM expects Vegas convention attendance to be up. Las Vegas Strip revenue are anticipate to grow slightly and Las Vegas Strip REVPAR is forcast to be up 1% to 3%.
American Tower Corp AMT Equity 3/29/218 $ 144.50 138 Long Limit $19,941.00 4/13/18 $ 135.24 138 $18,663.12 (1,277.88) -6.4% This industry is well needed now and forever in the future. Communication site and tower are very important for this growing area. The forward P/E for this stock is 42.74 and current P/E is 54.35. Has a loss of -4.5%. Sales fall. Has a loss of -6.4%. With fresh reports of a potential merger shaping up between Sprint and T-Mobile as soon as next week, communications tower firms that benefit from having four major wireless competitors are down again. American Tower is lower also from a cut to Neutral at New Street Research. The firm's trimmed its price target to $150 from $175 cutting implied upside to 6.4%.
Netflix Inc NFLX Equity 3/29/218 $ 284.03 70 Long limit $19,882.10 4/13/18 $ 311.76 70 $21,823.20 1,941.10 9.8% Netflix is a company that is the best in it's industry. It is starting to get out of debt and starting to see a net profit. It's net profit double from 2016 to 2017 to 4,033,000. Has a gain of 9.2%. Netflix stock jumps on news that big increases in new subscribers. Has a gain of 9.8%. Netflix announces that it intends to offer a $1.5B senior note issue. The interest rate, redemption provisions maturity date and other terms of the notes will be determined by negotiations between Netflix and the initial purchusers. The company plans to use the proceeds from the offering for general corporate purposes, which may include content acquisitions, production and development, capital expenditures, investment, working capital and potential acquisitions and strategic transactions. Bharti Airtel is negotiating with Netflix to add the streaming service for its Airtel TV app users, sources tell Economic Times. India-based Bharti Airtel operates in 16 nations in South Asia and Africa. Subscribers continue to be added and rising ASPs aren't deterring that growth.
Carmax KMX Equity 3/29/218 $ 61.78 323 Long Market $19,954.94 4/13/18 $ 62.86 323 $20,303.78 348.84 1.7% Carmax, last year had revenue growth of 4.79% and net income growth of 0.57%. The forward P/E for this stock is 13.89 and current P/E is 16.56. Has a loss of -0 .4%. Tariffs from Trump administration hold this stock back. Has a gain of 1.7%. Investors were expecting too much headed into the prior earnings report. The used car market is in a (near) perfect storm of inventory and marketability. Used unit same store sales dropped 8.0%. The stock had tumbled 12.2% over the past three months. The technical and the fundamentals imply there's at least a 19% upside from here.
Apple Inc AAPL Equity 3/29/218 $ 169.60 117 Long Market $19,843.20 4/13/18 $ 162.32 117 $18,991.44 (851.76) -4.3% Tim Cook is smart and intellengent CEO for Apple. The forward P/E for this stock is 14.97 and current P/E is 17.21. They have low debt. Has a gain of 2.9%. Sales are up. Has a loss of -4.3%. Apple Iphone 8 sales made up 23% of total Iphone sales for Q1, according to newly released CIRP data. The Iphone 8 Plus accounted for 21%, putting the lower cost models at 44% of the market. CIRP says the Iphone X share fell to 16% from 20% in the December quarter. Combined sales of the IPhone 8 models rose three percentage points in the same period, up from 41%. Other models: IPhone 7/7 Plus accounted for just under 20%, 6S/6SPlus was at 13%, and the SE took 8% of the market. In other Apple device news, the company is offering free replacement batteries for some newer 13 inch MacBook Pro models without failure that causes battery swelling.
Bank of America BAC Equity 3/29/218 $ 29.75 672 Long Market $19,992.00 4/13/18 $ 30.15 672 $20,260.80 268.80 1.3% The forward P/E for this stock is 11.99 and current P/E is 19.23. Beta is at 1.36. Last year BAC had revenue growth of 4.36% and net income growth of 2.30%. Has a loss of -0.6%. If you take out capital markets business and one-time events banks are not doing any business. Has a gain of 1.3%. Bank of America reported better-than-expected Q1 2018 results. Tax reform bill is being spun as a one time benefit, but the lower corporate tax rate significantly improves the bank's future earnings growth potential. Bank of America reported robust financial results for the first quarter. Strong loan and deposit growth underpinned the bank's first quarter profit growth. Higher net interest income is priced into Bank of America shares. The outlook is for strong operating income growth.
Proctor and Gamble Co PG Equity 3/29/218 $ 79.44 251 Long Market $19,939.44 4/13/18 $ 72.81 251 $18,275.31 (1,664.13) -8.3% A solid company that is at the lower stock price since a year and a half. With inflations looming it could good up to where it was. Even with stock prices falling it had a 45.85% net income growth in 2017. Has a loss of - 1.1%. Tariffs worries hit proctor and gamble. Has a loss of -8.3%. P & G earnings report signals some pricing pressure in the U.S. They reported organic sales increased 1.9% in Q1. While pricing was negative due largely to price cuts with U.S. shaving products. P&G stock fell 4% after earnings even though the results beat on the top and bottom line. P&G announced the acquisiton of Germany based Merck's consumer health product line. The deal boosts P&G presence in this a growth category.
First Solar FSLR Equity 3/29/218 $ 70.88 282 Long Market $19,988.16 4/13/18 $ 77.95 282 $21,981.90 1,993.74 10.0% First Solar designs and manufactures photovoltaic solar modules; develops, designs, and constructs utility-scale solar systems using the company’s modules; and provides operating services for the system owners. The company's solar modules use cadmium telluride to convert sunlight into electricity. This company's stock price has tripled in a year. Has a loss of - 0.4%. Tariffs are hitting solar company and prices will be raising and consumers will be buying less. Has a gain of 10.0%. Q1 net sales of $567M were down 36% from last year, but up 67% from Q4. They also topped estimates by $146M. End of year net cash balance is trimmed by $100M to $2-$2.2B thanks to higher capex for more Series 6 capacity. Net sales still seen at $2.45B-$2.65B, with gross margin of 21.5-22.5%. Company announces plans for a new facility near its Perrysburg, OH plant. The capital investment is seen at $400M, with 500 jobs to be created.
Qualcomm Inc QCOM Equity 3/29/218 $ 55.14 362 Long limit $19,960.68 4/13/18 $ 51.11 362 $18,501.82 (1,458.86) -7.3% A solid company that is investing in 5G bands heavily. Beta is 1.43. The forward P/E for this stock is 15.60 and current P/E is -19.49. Has a gain of 0.6%. Qualcomm refile to buy out NXP Semiconductors. Has a loss of -7.3%. Qualcomm hiked the quarterly dividend by 9% to $0.62. The unexpected high 4.7 % dividend yield is supported by a strong path to EPS growth. The company's licensing fees and operating income margins have been declining. Qualcom will cut 1,231 jobs in San Diego starting in June. It will also cut 269 positions in northern Calfornia.
Intel Corp INTC Equity 3/29/218 $ 51.08 391 Long Market $19,972.28 4/13/18 $ 52.73 391 $20,617.43 645.15 3.2% Intel Corp is one of the world's largest chipmakers. It designs and manufactures microprocessors and platform solutions for the global personal computer and data center markets. Beta is only at .95. Has a loss of -0.5%. Intel stock report drop because Apple will make there own Mac chips. Has a gain of 3.2%. The company announced that mass production of its 10nm Cannon Lake chips would again be delayed. Low volume shipments already started but volume production now shifts to 2019 instead of the end of the year. TSMC already has its 10nm chips available and Samsung is on its second-gen 10nm CPUs. Samsung could have 8nm chips in production by the time Cannon Lake hits volume. Intel pops 8.2% aftermarket on Q1 results that beat EPS and revenue estimates. Upside Q2 guidance has revenue from $15.8B to $16.8B.
Walmart WMT Equity 3/29/218 $ 88.73 225 Long Market $19,964.25 4/13/18 $ 87.29 225 $19,640.25 (324.00) -1.6% I like this store the best compared to others stores like Target, or Sams, and BJs. Walmart is definitely the store that has the best prices on their products. The forward P/E for this stock is 18.21 and current P/E is 23.64. Has a loss of - 2.8%. Walmart going to spend $200 million to construct and remodel new stores. Has a loss of -1.6%. After a negative earnings miss and tepid online growth result the declined 12% over the last month. The primary reasons for the earnings miss were temporary in nature and related to a strategic shift to online and groceries. Walmart is reportedly close to buying 51% of Flipkart for $10-$12 billion in order to gain access to the e-commerce market in India. Flipkart is one of the largest domestic e-commerce players. It has grown rapidly by offering steep discounts to attract customers. If the acquisition takes place, it could raise Walmart's gearing from 46% to 63%. Overall revenue will increase by 0.7% but earnings could fall by 6%.
Coca-Cola Bottling Co Conso COKE Equity 3/29/218 $ 174.49 114 Long Market $19,891.86 4/13/18 $ 167.50 114 $19,095.00 (796.86) -4.0% My favorite soda is coca-cola. They are the best in their industry. The forward P/E for this stock is 36.98 and current P/E is 92.51. Has zero loss or gain. China tariffs level off Coke gains. Has a loss of -4.0%. Coca-cola Bottling declares $0.25 shares quarterly dividend, in line with previous. Forward yield 0.58%. Payable May 11 for shareholders of record April 27.
Alibaba Group Holding BABA Equity 3/29/218 $ 183.10 109 Long Market $19,957.90 4/13/18 $ 177.16 109 $19,310.44 (647.46) -3.2% Alibaba is the world’s largest online and mobile commerce company, measured by GMV. It operates China’s most-visited online marketplaces, including Taobao (C2C) and Tmall (B2C). Alibaba's China marketplaces accounted for 76% of revenue in fiscal 2017. This stock has almost doubled in a year. Has a loss of -5.8%. Alibaba stock price target cut to $219 from $228. Has a loss of -3.2%. Alibaba is slowly building a decent presence in the Indian market through its investment. Recent trade war fears have sent Alibaba stock tumbling in a matter of weeks. Alibaba's Tmall Genie smart assistant is coming to Chines Mercedes Volvos, and Audis. The new partners bring Alibaba's total to around 100. Alibab has also sold more than 2M speakers featuring Genie.
General Electric GE Equity 3/29/218 $ 13.44 1,488 Long Market $19,998.72 4/13/18 $ 14.38 1,488 $21,397.44 1,398.72 7.0% General Electric is a diversified manufacturer that operates seven separate businesses in its industrial segment: power, oil and gas, renewable energy, lighting, aviation, healthcare, and transportation. GE stock is the lowest price it has been in 10 years so at some point it has to go up. Has a gain of 0.1%. Slow growth in sales. Has a gain of 7.0%. After a strong rally from a 52 week low, GE has come again under pressure this week. Its long term bonds hit a multi-year low. The book value of its most liquid assets is rapidly falling. At $14 a share where GE currently trades, it doesn't look incredibly overvalued buti it's not a bargain. The test of GE Renewable Energy's Haliade-X 12 megawatt turbine will take place at a facility in northeast England.
Verizon Communication Inc VZ Equity 3/29/218 $ 48.07 416 Long Market $19,997.12 4/13/18 $ 51.57 416 $21,453.12 1,456.00 7.3% Verizon is another company that is going to see profits with the 5G networks being updated. Beta is only at 0.65. The forward P/E for this stock is 0.04 and current P/E is 129.31. Has a gain of 0.5%. Slow new customer growth. Has a gain of 7.3%. Verizon combined good operational results and tight opex management with easy comps and tax tailwinds to deliver solid 1Q18 results. Verizon up 2.5% from Q1 earnings. Postpaid smartphone net adds were 220,000. The compnay posted 260,000 net adds in retail postpaid connections: net phone losses of 24,000 and tablet losses of 75,000, offset by gains of 359,000 in other devices. Services revenues, $26.7B up 2.6% and wirless equipment revenues, $5.04B up 33.9%.
JPMorgan Chase & Co JPM Equity 3/29/218 $ 109.97 181 Long Market $19,904.57 4/13/18 $ 109.40 181 $19,801.40 (103.17) -0.5% JPMorgan Chase is one of the largest financial institutions in the United States, with more than $2.5 trillion in assets and operations in dozens of countries. The company is organized into several business segments: investment banking, commercial banking, treasury and securities services, asset management, retail financial services, and credit card businesses. This stock has doubled in 5 years. Has a gain of 0.3%. If you take out capital markets business and one-time events banks are not doing any business. Has a loss of -0.5%. Q1 earnings were up thanks to lower corportate tax rates. The key growth catalysts- economic growth and rising interest rates - remain intact. Loan growth remains stagnant, but net interest margins are still low so that the real performance must come from other areas of the bank. Looking to streamline origination, settlement, interest rate payments and other processes has tested a new blockchain platform for issuing financial instruments with the National Bank of Canada.
Tesla Inc TSLA Equity 3/29/218 $ 255.38 78 Short Limit $19,919.64 4/13/18 $ 294.08 78 $22,938.24 3,018.60 15.2% Tesla is an intersting company that has products in the car industry, solar panels industry, and their new project Space x. Beta is at 1.17. This company's stock price has doubled in 4 years. Has a gain of 13.4%. Stock rose because new that company will not need to raise cash this year. Has a gain of 15.2%. Musk has now pledged more than 13.7 million shares as collateral. Model 3 peak production rate in Q2 = 250% Q1. Model 3 total production Q1 = 9,766 vs. Q4 est = 81,000. Net profit for 2018 may be less than $700 million. Model Y pre oders may increase 2018 cash on hand by $1 billion.
Nike NKE Equity 3/29/218 $ 66.14 302 Short Market $19,974.28 4/13/18 $ 69.53 302 $20,998.06 1,023.78 5.1% Nike had their stock price double in a year. The best shoe apparel store in the industry. Beta is at 0.66. Has a gain of 1.2%. New product sales bump up stock price. Has a gain of 5.1%. The condidence in Nike is tied to the company being on the right side of future consumer lifestyle preferences. Health is one of the key concerns of consumers for the future and whether it's actually practicing sports or wearing sporting goods because it makes you feel better, there will be a need for these products now and in the future. Nike's China business represents more of a risk to the bottom line than the top line in light of the trade tension between the U.S. and China. Nike agrees to acquire Israeli computer vision company Invertex, which makes software that scans a customer's body for product fittings, for an undisclosed sum. Invertex is the second company NKE has acquired in less than a month as part of its Consumer Direct Offense strategy to strengthen its digital technology after buying data analytics company Zodiac in March.
Red Hat Inc RHT Equity 3/29/218 $ 148.18 134 Short Market $19,856.12 4/13/18 $ 163.31 134 $21,883.54 2,027.42 10.2% Stock has double in a year time. Beta is a 1.07. Last year RHT had revenue growth of 17.52% and net income growth of 27.26%. Has a gain of 5.5%. Sales has been up. Has a gain of 10.2%. Red Hat shares up 6.2% on Q4 results that beat EPS and revenue estimates with a 23% revenue growth Y/Y. Q1 guidance has upside revenue from $800M to $810M and downside EPS of $0.68. FY guidance has revenue from $3.425B to $3.46B, non-GAAP operating margin at 23.9% EPS from $338 to$3.41, and operating cash flow from $1.035B to $1.045B.
Exxon Mobil Corp XOM Equity 3/29/218 $ 74.61 268 Short Market $19,995.48 4/13/18 $ 77.79 268 $20,847.72 852.24 4.3% ExxonMobil is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2017, it produced 2.3 million barrels of liquids and 10.2 billion cubic feet of natural gas per day. This stock price is at the lowest it has been since 2006. Has a gain of 4.3%. Gas prices were on the rises. Has a gain of 4.3%. Exxon earnings increase 16 percent to $4.7 billion in first FY18. Increased commodity prices, coupled with a focus on operating efficiently and strengthening our portfolio resulted in higher earnings and the highest quarterly cash flow from operations and asset sales since 2014. Through new discoveries and acquired acreage, they positioned Upstream portfolio well for future growth. Made good progress on plans to improve the production mix and grow premium product sales in the Downstream and Chemical businessess. Higher prices reduced entitlement volumes. Natural gas prices were supported by strong seasonal demand with colder weather across Europe and U.S. 5M shares bought back during Q1 for $425M in order to offset dilution from stock-based compensation. Buybacks will be continued for this purpose, but there are no plans to reduce the float.
Lowe's Companies Inc LOW Equity 3/29/218 $ 86.94 230 Short Market $19,996.20 4/13/18 $ 84.00 230 $19,320.00 (676.20) -3.4% Lowe's is the second- largest home-improvement retailer in the world and operates more than 2,100 stores throughout the United States, Canada, and Mexico. This stock price has doubled in 4 years. Beta is at 1.32. Has a loss of -1.7%. Company's earnings of 74 cents per share fell short. Lowe's has invested a great deal in their e-commerce and Buy Online Pick Up in store concepts that have resonated well with consumers. Lowe's has potential to close the gap and increase shareholder returnd at a quicker pace combined with further dividend increases. Has a loss of -3.4%. 9.23 million shares traded hands. The relative volume of the stock is 1.24 while its market cap is 71.06 billion. Analysts have given a rating of 1.90 on company shares on a consensus basis, EPS growth is noticed at 18.40% for the year and anticipated 12.36% growth for next year. The stock has gathered a -1.89% return in the past 5 trading days. The stock is weak among movers in the past month as it showed -3.12% return.
$557,821.79 $567,078.90
Union Pacific - 8.0% - Jan 2021 B-UNP-8.0-10012021 Debt 4/13/218 $ 1,051.00 23 Long Market $24,173.00 4/13/218 $ 1,045.00 23 $24,173.00 (138.00) -0.57% I bought this one because the interest rate was a excellent return rate for the time period. Has a loss of -0.57%. It took awhile for the recent Interest rate spikes to effect the price of the bond. Possible ones in the near future will cause it decline slowly.
Altria Group Inc - 2.85% - Aug 2022 B-MO-2.85-09082022 Debt 4/13/218 $ 980.90 25 Long Market $24,552.50 4/13/218 $ 973.95 25 $24,552.50 (173.75) -0.7% I bought this one because the interest rate was good return for its time period. Has a loss of -0.7%. The price of the bind has decreased because of the overall stock market dip and the threat of rising interest rates in 2018 by the FED
Philip Morris - 1.875% - Jan 2019 B-PM-1.875-15012019 Debt 4/13/218 $ 997.61 25 Short Market $24,940.25 4/13/218 $ 994.74 25 $24,940.25 (71.75) -0.3% I bought this one because the interest rate was at a good return rate and Philip Morris is a good company. Has a loss of -0.3%. It took awhile for the recent Interest rate spikes to effect the price of the bond. Possible ones in the near future will cause it decline slowly.
T-NOTE 1.000% 30-Sep-2019 B-T-1.000-30092019 Debt 4/13/218 $ 981.56 25 Short Market $24,539.00 4/13/218 $ 980.86 25 $24,539.00 (17.50) -0.1% I bought this one because the interest rate and the time period was a good return. Has a lossof -0.1%. Yields on Treasury securities at constant maturity are determined by the U.S. Treasury from the daily yield curve. Treasury securities are considered risk-free since they are backed by the U.S. government.
Apple - 0.488% - May 2018 B-AAPL-0.488-03052018 Debt 4/13/218 $ 999.50 25 Short Market $24,987.50 4/13/218 $ 999.34 25 $24,987.50 (4.00) -0.0% I bought this one because Apple is a solid company to invest in and for the short term rate and it a good buy. No gain or loss. Bond prices have been steadily in decline since the beginning of the year as inflation pressures increased and the chance of a more ready to move Federal Reserve grew more likely. Apple has docked a large chunk of its overseas cash in corporate securities in recent years as it avoided repatriation.
Name Symbol Type Purchase Date Options Purchased Option Strike Price Maturity Option Price Security Price Purchase Amount Date Option Price Security Price Market Profit Return Purchase Notes Final Assessment
Johnson & Johnson JNJ1720J130 buy/call 4/27/218 10 128.00 5/11/218 2.00 128.27 $2,000.00 4/27/218 2.00 137.00 $2,000.00 0.00 0.0% Buying because close to its lowest price since a year because of judgement in hip implant case. JNJ reported solid Q1 results but the stock is off over 3% post-earnings. The company expects single digit organic revenue growth for 2018. Its EPS is expected to grow around 11%.
Wal-Mart WMT1720V75 buy/put 4/27/218 10 89.00 5/11/218 3.00 87.29 $3,000.00 4/27/218 3.00 72.00 $3,000.00 0.00 0.0% Buying because this is a value stock that is underperforming. Shares are down over 20% following a slowdown in the growth of online sales.
Ameren Corp AEE1715X45 sell/call 4/27/218 10 55.00 5/18/218 4.00 58.60 $4,000.00 4/27/218 4.00 57.00 $4,000.00 0.00 0.0% Selling because of fears that stronger inflation would push yields higher which would make dividend oriented utilities less attractive. Utilities have suffered their worst two-month return since 2009 lows led to bounces in the XLU. Expect a further 7% or 9% drop in utility stock prices before valuations look much more attractive in early spring.
Ford BSX1717K25 sell / put 4/27/218 10 13.00 5/11/18 2.00 11.49 $2,000.00 4/27/218 2.00 13.00 $2,000.00 0.00 0.0% Selling because Ford vehicle buying have signs of stress from ecomony. A prove into sedans made by Ford is expanding to cover a million cars as National Highway Safety Admin looks further into faulty brake parts. Ford hasn't declared the issue an unreasonable risk to safety which would prompt a recall

Options

Name Symbol Type Purchase Date Options Purchased Option Strike Price Maturity Option Price Security Price Purchase Amount Date Option Price Security Price Market Profit Return Purchase Notes Final Assessment
Johnson & Johnson JNJ1720J130 buy/call 7/5/17 10 137.00 7/30/17 2.00 135.00 $2,000.00 19-Jul 3.00 137.00 $3,000.00 1,000.00 50.0% Despite companies underperformance, its shareholder value continues to increase along with dividend and international growth potential Continue to hold per J&J’s share price is up 14.7% so far this year. Second-quarter sales grew 1.6% in the domestic market to $9.73 billion and 2.3% in international markets to $9.11 billion, reflecting 4.4% operational growth, partially offset by a 2.1% negative currency impact. JNJ is "in the money"
Wal-Mart WMT1720V75 buy/put 7/5/17 10 76.00 7/31/17 3.00 74.00 $3,000.00 19-Jul 4.00 72.00 $4,000.00 1,000.00 33.3% Despite companies underperformance, its shareholder value continues to increase along with dividend and international growth potential Continue to hold per Wal-Mart valued 4 times greater than CVS by restructuring wages for employees and invested in digital retail and information technology. WMT is "in the money"
Ameren Corp AEE1715X45 sell/call 7/5/17 10 55.00 8/1/17 4.00 53.00 $4,000.00 19-Jul 5.00 57.00 $5,000.00 (1,000.00) -25.0% Selling put due to the stock being overvalued with a current trailing 12-month EV/EBITDA ratio of 9.18, which is much higher than the average level of 8.98. Ameren relies on fossil fuel mostly to provide electricity to customers and must make huge investments to comply with the new law which may impact their profitability. Minimum concern per utility company with beta of 0.36, PE ratio of 3.08, and dividend yield of 3.18%. Continue to hold due to sustainability and techonogical contributions to industry
Becton Dickinson & Co BSX1717K25 sell / put 7/5/17 10 28.00 8/2/17 5.00 26.00 $5,000.00 19-Jul 6.00 24.00 $6,000.00 (1,000.00) -20.0% BSX is considered as a high risk investment due to its high liquidity and asset's high volatility. It currently has a beta of 1.05, PE ratio 20.69 and dividend of 2.92. Although high volatility, BDX has gained 3% shares in May allowing the company to outperform the market Continue to hold per market cap of 45.70B. BSX is "in the money"

what i've learned

Results
Name Profit Return What I've learned: 06/23/17-07/19/17
Alaphabet Inc $521.00 2.7% Was a bit concerned due to flucuation in earnings growth since earnings were flat from 2011 t0 2016. However, future net income has increased which makes this investment worthwhile.
Visa $1,067.13 5.3% Not surprised at all since stocks immediately declined last quarter after announcing the loss of exclusivity of certain brands
Dollar General $1,059.30 5.3% MRK stocks have fallen after the multiple deaths associated with Keytruda as well as the FDA placing a hold to conduct an investigation. Merck stock was off an additional 1%, near 63.50. It ended the regular trading session down a fraction, to 64.16. Shares have been forming a flat base since early March.
Skyworks Solutions Inc -$2,584.00 -12.9% UNH increased their Market Cap rank which enables investors to compare the value of two stocks. UNH market cap is now $180.15 billion compared to Verizon Communications Inc at $177.53 billion. Still a good long term investment
McDonald's Corp $243.84 1.2% MDT has a dividend yield of 1.84, beta of 1.04, PE ratio of 2.40%. Would have expected a better return considering the low beta
Amazon $2,514.68 12.9% AMGN has respectable returns despite concerns that a certain drug causes issues with the heart.
Home Depot $920.64 1.2% ABBV should have better returns since a 10% run up of value growth and gain were increased
MGM Resorts International -$2,135.54 -10.7% CELG stocks are up due to multiple collaboration deals and enhances their oncology portfolio after closing a deal with BeiGene in China. Would expect better returns due to company's financial history
American Tower Corp -$1,277.88 -6.4% BMY has a beta of 1.17. Not expecting much due to beta and shares have reduced due to drug concerns
Netflix Inc $1,941.10 9.8% GILD share price has increased recently and accumulated sales in excess of $1.0 billion with trailing price earnings ratios of less than ten. Definitely satisfied with return
Carmax $348.84 1.7% Was not expecting such a hit considering Allergan has become a “branded biopharmaceutical leader” and has an adequate size consumer base thinking that stocks would increase
Apple Inc -$851.76 -4.3% Great return considering cash & equivalents were 4.58B in 2016. Also, has exceptional beta of 0.35, dividend yield 2.08, & market cap of 90.04B
Bank of America $268.80 1.3% Not expecting such a great return, but TMO has outperformed the market with a 4.3% gain over S&P 500
Proctor and Gamble Co -$1,664.13 -8.3% Under performed the markets, but still posted positive gains
First Solar $1,993.74 10.0% Beta at 0.78. On Apr 25, 2017, BIIB Inc reported 1st quarter 2017 earnings of 5.20 per share, outperforming the market
Qualcomm Inc -$1,458.86 -7.3% DHR net income decreases annually, but revenues are not impacted and tend to rise annually. Have to pay attention since dividend yields tend to fluctuate
Intel Corp $645.15 3.2% Continues to outperform the market providing an excellent return. Anthem Inc reported 1st quarter 2017 earnings of 4.68 per share. This result exceeded the 3.88 consensus of the 17 analysts covering the company and exceeded last year's 1st quarter results by 35.26%.
Walmart -$324.00 -1.6% stocks have continued to rise over resulting in a great profit
ERROR:#REF! ERROR:#REF! ERROR:#REF! SYK has outperformed the market with prices steadily increasing. Great investment due to future growth and earnings potential
Coca-Cola Bottling Co Conso -$796.86 -4.0% BDX is considered as a high risk investment due to its high liquidity and asset's high volatility. It currently has a beta of 1.05, PE ratio 20.69 and dividend of 2.92. Although high volatility, BDX has gained 3% shares in May allowing the company to outperform the market
Alibaba Group Holding -$647.46 -3.2% Good returns considering CI reported 1st quarter 2017 earnings of 2.77 per share resulting in an increase from the previous year
General Electric $1,398.72 7.0% Decent profit since growth in earnings per share excluding extraordinary items increased 51.39%. Stocks are improving due to five year annualized earnings per share growth ranks highest in the industry.
Verizon Communication Inc $1,456.00 7.3% BSX predicted to outperform the market considering stock prices are increasing
JPMorgan Chase & Co -$103.17 -0.5% Shares continue to increase and HUM will outperform the market. Nice profit considering prices falling previously due to annoucement of exiting ObamaCare in 2018
Tesla Inc $3,018.60 15.2% Stock prices continue to flucuate, but REGN revenue ending in 2016 was 4.86bn. Best return considering revenue and net income improved
Red Hat Inc $2,027.42 10.2% MCK stock is relatively undervalued since their stock’s PE also compares favorably with the Zacks classified Medical sector’s trailing twelve months PE ratio which stands at 19.90
Exxon Mobil Corp $852.24 4.3% Excellent beta 0.39, PE ratio 4.91, & dividend 0.00. Has overperformed for the last 3 months and rallied 20.9% in this period, compared with the market’s mere 2.7% gain.
Lowe's Companies Inc -$676.20 -3.4% VRTX share price is up 84% so far this year, comparing favorably to an increase of 10.6%for the Zacks-classified Biomedical-Genetics industry. Not sure how this impacted the portfolio so negtively with positive reviews
0 $0.00 0.0% ZTS reported 1st quarter 2017 earnings of 0.530 per share. This result exceeded last year's 1st quarter results by 10.42% enabling the company to outperform the market. Expected higher profit
0 $0.00 0.0% BAX has an excellent beta of 0.66, but dividends decreased last year and stock prices continues to flucuate. Also, dividend per share growth is below the industry average relative to its peers, while earnings per share growth is the above the industry average.
Bonds
Union Pacific - 8.0% - Jan 2021 -$138.00 -0.6% Practical investment since Fed rate did not increase and Treasury Bond ETF TLT, -0.60% has been effectively flat since mid-November. Bonds are long tem and better regarding asset allocation
Altria Group Inc - 2.85% - Aug 2022 -$173.75 -0.7% Short term bonds ensures less debt if rates are inflated and lower yielding bonds decrease. Consumer spending has improved & companies should have the ability to pay off debt in the short run.
Philip Morris - 1.875% - Jan 2019 -$71.75 -0.3% Utilizing debt to pay shareholders while holding most of its $256 billion in cash overseas to avoid repatriation taxes. Apple stock, which hit record highs earlier this week that made it the first company with an $800 billion market cap, fell 0.1% at $153.84 after hours.
T-NOTE 1.000% 30-Sep-2019 -$17.50 -0.1% Westpac 10 year annualized default probability is only 0.04%, among the lowest in the world. Westpac Banking Corporation bonds offer exceptionally good value. Only 5 of 422 heavily traded bonds offered better value, as measured by the credit spread to default probability ratio, than the best Westpac Banking Corporation bond issue.
0 $0.00 0.0% Convertible bond , but have risks of low or high levels of imlpied volatility. Options traders look for options with high levels of implied volatility to sell premium.
Options
Johnson & Johnson $1,000.00 50.0% The Options portion was rather diffifcult than expected. I tried to make "smart" decisions, but kept receiving error messages such as; Instrument symbol must be specified.
Wal-Mart $1,000.00 33.3% canceled transaction due to uncertainty
Ameren Corp -$1,000.00 -25.0% canceled transaction due to uncertainty
Becton Dickinson & Co -$1,000.00 -20.0% Tried to execute a spread: buy to open/sell to open with same symbol, but received error message stating symbols must be slightly different

Majority of my investment learnings were associated with the options portion and how to determine the correct quantity along with the appropriate action to take in order to receive a profit. Trading options was the most difficult portion to learn, but through all the frustration I have actually learned quite a bit and currently feel more comfortable with understanding trading in general. In addition, I have learned that: 1) Before this class, I only knew about stocks and did not realize the difference between actual stocks and ETF's. Now, I understand that ETFs tracks an index, commodity, bonds, or a basket of securities while stocks focus on one firm. 2) PE ratio, beta, and dividend yield are aspects of valuation method that enables investors to compare firms. Also, intrinsic or relative valuations models are the most commonly used. 3) Stop-loss order were used primarily for long term investments, but also used it on a few short term investments when trades were above a specific price. 4) Options were difficult to tackle, but they offer a gain or loss since they are volatile and move quickly. Firms sell options for short- to medium-term value-creation benefits. 5) Although my portfolio represents majority stocks in the healthcare industry, my portfolio value and buying power has increased overall. My portfolio displays a sizeable cash balance despite substanial financial upsets. Overall, majority of healthcare stocks are "in the money" and are worth exercising.